InGeneron
InGeneron enables novel, safe, and evidence-based therapies that unlock the healing potential of each patient's own regenerative cells.
About InGeneron
InGeneron is a clinical stage cell therapy company. We believe that evidence-based regenerative therapy will redefine the health care experience. Its system is designed to enable doctors to heal patients safely and quickly by unlocking and using the healing potential of their own regenerative cells. Founded in 2006, we are a Houston-headquartered, privately held company that was formed to innovate cell-based technologies for health care and life science research. The work of our scientists and doctors in the field of the stem and regenerative cell research has enabled us to develop a regenerative cell therapy product platform for multiple potential applications. This work has yielded numerous peer-reviewed publications and studies on the use of autologous adult stem cells – those that are extracted from and reintroduced into the same person – to promote healing.
Company Facts
- Headquarters
- Houston
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- private
- Employees
- c_00011_00050
- Total Funding
- $52,749,186
- Last Funding Type
- series_unknown
- Last Funding Date
- 2024-03-01
- Website
- ingeneron.com
Industries & Categories
Alternative Medicine, Biotechnology, Health Care, Therapeutics
Social Links
Canonical: https://fsome.com/organization/ingeneron-150186 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.